In vivo, compared with Free SHK and Lip-SHK, RGD-Lip-SHK could effectively mediate active targeting, and accumulate substantially at the tumor site with long circulation, thereby presenting the strongest antitumour-targeted efficacy. This evidence concerns the gene SHPK and neoplasm.